Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs

Introduction: Acromegaly is a rare, serious endocrine disorder characterized by excess growth hormone (GH) secretion by a pituitary adenoma and overproduction of insulin-like growth factor I (IGF-I). Transsphenoidal surgery is the treatment of choice, although many patients require additional interv...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Endocrinol (Lausanne)
Egile Nagusiak: Gadelha, Mônica, Bex, Marie, Colao, Annamaria, Pedroza García, Elier Mitsael, Poiana, Catalina, Jimenez-Sanchez, Marisela, Yener, Serkan, Mukherjee, Rishav, Bartalotta, Amy, Maamari, Ricardo, Raverot, Gérald
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7008501/
https://ncbi.nlm.nih.gov/pubmed/32117045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00931
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak